We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Aflac
AFL
$64.8B
| $49.3M | 0.14% |
1,539,842
-59,336
| -4% | -$1.81M |
|
152
State Street
STT
$50.2B
| $48.9M | 0.14% |
665,209
-7,875
| -1% | -$589K |
|
153
Allstate
ALL
$68.3B
| $48.8M | 0.14% |
685,944
-15,998
| -2% | -$1.13M |
|
154
Northrop Grumman
NOC
$76B
| $48.8M | 0.14% |
303,192
-7,512
| -2% | -$1.2M |
|
155
Archer Daniels Midland
ADM
$38.9B
| $48.7M | 0.14% |
1,027,511
-4,049
| -0.4% | -$193K |
|
156
Eaton
ETN
$150B
| $47.7M | 0.14% |
702,214
-48,150
| -6% | -$3.27M |
|
|
PARA
157
DELISTED
Paramount Global Class B
PARA
| $47.1M | 0.14% |
776,439
-37,609
| -5% | -$2.2M |
|
158
Corning
GLW
$116B
| $47M | 0.14% |
2,073,892
-61,800
| -3% | -$1.47M |
|
|
PCP
159
DELISTED
PRECISION CASTPARTS CORP
PCP
| $47M | 0.14% |
223,591
-6,777
| -3% | -$1.44M |
|
160
Micron Technology
MU
$988B
| $46.7M | 0.13% |
1,722,271
-16,169
| -0.9% | -$483K |
|
|
VIAB
161
DELISTED
Viacom Inc. Class B
VIAB
| $46.4M | 0.13% |
680,013
+14,650
| +2% | +$1.01M |
|
162
Truist Financial
TFC
$63.5B
| $46.2M | 0.13% |
1,184,432
+78,606
| +7% | +$2.96M |
|
163
Cummins
CMI
$87.3B
| $45.6M | 0.13% |
328,952
+8,806
| +3% | +$1.24M |
|
164
Exelon
EXC
$46.6B
| $45.6M | 0.13% |
1,900,167
-14,228
| -0.7% | -$352K |
|
165
Marathon Petroleum
MPC
$91.7B
| $44.5M | 0.13% |
869,942
-22,980
| -3% | -$1.1M |
|
166
American Electric Power
AEP
$69.5B
| $44.4M | 0.13% |
789,857
-8,234
| -1% | -$489K |
|
167
Cigna
CI
$76.1B
| $43.4M | 0.13% |
335,339
-11,312
| -3% | -$1.31M |
|
168
Southwest Airlines
LUV
$22.3B
| $43M | 0.12% |
969,734
-6,744
| -0.7% | -$295K |
|
169
Broadcom
AVGO
$1.85T
| $42.4M | 0.12% |
3,341,730
+72,270
| +2% | +$829K |
|
|
CB
170
DELISTED
CHUBB CORPORATION
CB
| $42.2M | 0.12% |
417,283
-41,987
| -9% | -$4.25M |
|
|
BHI
171
DELISTED
Baker Hughes
BHI
| $42M | 0.12% |
659,992
-66,257
| -9% | -$4M |
|
172
Crown Castle
CCI
$33.4B
| $41.1M | 0.12% |
497,559
+1,870
| +0.4% | +$159K |
|
|
MHFI
173
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $40.6M | 0.12% |
393,008
-2,044
| -0.5% | -$201K |
|
174
Vertex Pharmaceuticals
VRTX
$122B
| $40.6M | 0.12% |
343,819
+3,623
| +1% | +$434K |
|
175
Aon
AON
$78.3B
| $40.2M | 0.12% |
418,587
-26,816
| -6% | -$2.59M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.